Open-label Pilot Study of Abatacept for the Treatment of Vitiligo
Clinical trial NCT02281058 · UNKNOWN
Trial details
- NCT number
- NCT02281058
- Sponsor
- Brigham and Women's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.